Current Trials

F00523 Recombinant Protein Influenza Vaccine

 Fusion Norwood

A potential new influenza vaccine using recombinant protein vaccine technology compared with currently approved flu vaccines is currently being trialled at Fusion Norwood. You may be eligible to participate in this trial, register your interest or get in contact with us today!


Eligibility requirements

  • Age: 18 - 60yrs
  • Sex: M & F
  • BMI: 19 - 40
  • Medication: – Must be fully vaccinated with licensed COVID-19 vaccines – Must not have another influenza vaccine within 6 months prior to planned vaccination


  • up to $450 if you complete all study requirements

How to apply

To register your interest in this trial, please complete this form, or call us on 1800-FUSION (1800 387 466). A Fusion team member will be in contact to discuss your eligibility shortly.